Incidentaloma adrenal e hipertensión arterial

Grumbach, 2003, Management of the clinically inapparent adrenal mass (“incidentaloma”), Ann Intern Med, 138, 424, 10.7326/0003-4819-138-5-200303040-00013 Young, 2007, Clinical practice. The incidentally discovered adrenal mass, N Engl J Med, 356, 601, 10.1056/NEJMcp065470 Gordon, 1994, High incidence of primary aldosteronism in 199 patients referred with hypertension, Clin Exp Pharmacol Physiol, 21, 315, 10.1111/j.1440-1681.1994.tb02519.x Mulatero, 2004, Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents, J Clin Endocrinol Metab, 89, 1045, 10.1210/jc.2003-031337 Connell, 2005, The new biology of aldosterone, J Endocrinol, 186, 1, 10.1677/joe.1.06017 Milliez, 2005, Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism, J Am Coll Cardiol, 45, 1243, 10.1016/j.jacc.2005.01.015 Montori, 2002, Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature, Endocrinol Metab Clin North Am, 31, 619, 10.1016/S0889-8529(02)00013-0 Stowasser, 2003, Primary aldosteronism, Best Pract Res Clin Endocrinol Metab, 17, 591, 10.1016/S1521-690X(03)00050-2 Stowasser, 2001, Familial hyperaldosteronism, J Steroid Biochem Mol Biol, 78, 215, 10.1016/S0960-0760(01)00097-8 Magill, 2001, Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism, J Clin Endocrinol Metab, 86, 1066, 10.1210/jc.86.3.1066